These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 759246)

  • 1. Detection of early retinal changes in diabetes by vitreous fluorophotometry.
    Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
    Diabetes; 1979 Jan; 28(1):16-9. PubMed ID: 759246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous fluorophotometry in juvenile diabetes.
    Kernell A; Larsson Y; Ludvigsson J; Tenland T
    Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of retinal involvement in diabetes by vitreous fluorophotometry.
    Cunha-Vaz JG; Goldberg MF; Vygantas C; Noth J
    Ophthalmology; 1979 Feb; 86(2):264-75. PubMed ID: 530578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.
    Waltman SR
    Trans Am Ophthalmol Soc; 1984; 82():827-49. PubMed ID: 6535330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes.
    Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
    Am J Ophthalmol; 1978 Oct; 86(4):467-73. PubMed ID: 707592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early diagnosis of diabetic retinopathy in patients with diabetes type I, using vitreous fluorophotometry].
    Janiec S; Sośnierz-Jupowiecka A; Rzendkowski M
    Klin Oczna; 1994; 96(8-9):265-7. PubMed ID: 7897991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new method in the analysis of vitreous fluorophotometry. Results in early diabetic retinopathy].
    Roy MS; Bungay P; Collier B; Bonner R
    Ophtalmologie; 1989; 3(3):214-6. PubMed ID: 2641114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous fluorophotometric evaluation of diabetics.
    Bursell SE; Delori FC; Yoshida A; Parker JS; Collas GD; McMeel JW
    Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):703-10. PubMed ID: 6724841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous variation in vitreous fluorophotometry.
    Ross S; Arffa R; Miller D; Weiss JN; Ransil BJ
    Ann Ophthalmol; 1982 Mar; 14(3):245-9. PubMed ID: 7092034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
    Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
    Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative vitreous fluorophotometry. A sensitive technique for measuring early breakdown of the blood-retinal barrier in young diabetic patients.
    Waltman SR; Oestrich C; Krupin T; Hanish S; Ratzan S; Santiago J; Kilo C
    Diabetes; 1978 Feb; 27(2):85-7. PubMed ID: 624444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M
    Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
    Bordat B; Guirgis IR; Manderscheid JC
    J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of therapy on vitreous fluorophotometry in diabetes mellitus.
    Waltman SR; Krupin T; Singer P; Becker B
    Trans Ophthalmol Soc U K (1962); 1979 Apr; 99(1):8-9. PubMed ID: 297386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of retinal argon laser photocoagulation on results of vitreous fluorophotometry in patients with diabetic retinopathy].
    Gierek-Lapińska A; Formińska-Kapuścik M; Janiec S; Rzendkowski M
    Klin Oczna; 1994; 96(8-9):263-4. PubMed ID: 7897990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structural and functional disorders of transcapillary metabolism if retina in patients with diabetic retinopathy].
    Sorokin EL; Smoliakova GP
    Vestn Oftalmol; 1997; 113(2):16-9. PubMed ID: 9229896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative vitreous fluorophotometry in insulin-treated cystic fibrosis patients.
    Rodman HM; Waltman SR; Krupin T; Lee AT; Frank KE; Matthews LW
    Diabetes; 1983 Jun; 32(6):505-8. PubMed ID: 6628836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
    Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surveillance using vitreo-fluoro-photometry of diabetics treated with an insulin pump, without or with minimal retinopathy. Results after 3 years].
    Bordat B; Misse P; Zaluski S; Rouault R; Mirouze J
    J Fr Ophtalmol; 1989; 12(6-7):421-5. PubMed ID: 2636237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.